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Background
Heterosexual contact is a major route for HIV-1 transmis-
sion and cervicovaginal secretions (CVS) contain both
cell-associated and cell-free virus. Nevertheless, these dif-
ferent forms of HIV-1 and their involvement in sexual
transmission have been poorly characterized.
Methods
CVS and blood were sampled in 80 HIV-1 infected
women. Cells phenotype was analyzed by flow cytometry
and levels of spontaneous HIV-1-antigen secreting CD4+ T
cells were evaluated by ELIspot assay. Cell-free virus was
quantified in CVS and paired plasma while cell-associated
virus was assayed in cell-culture supernatants.
Results
Cell-free HIV-1 RNA was frequently detected in CVS from
patients viremic for HIV RNA in plasma but was unusual
in aviremic patients (75% versus 16%, and mean = 5921
copies/ml versus 2696 copies/ml, respectively, P < 0.001).
Levels of HIV-1 RNA were positively correlated in CVS and
plasma (ρ = 0.7, P < 0.001). CVS contains low T lym-
phocytes quantities (mean = 120 CD4+ cells/ml and 133
CD8+ cells/ml) and CVS-derived CD4+ T cells are mostly
memory and activated lymphocytes (CD45RA-, HLA-DR+,
CD38+, CD69+). Those cells were strikingly different from
blood CD4+ T cells with a phenotype exhibiting a mucosal
profile with higher expression of CD103 combined with
lower expression of CCR7. Cell-associated HIV-1 RNA was
detectable in only 3/51 CVS including 2 from viremic
patients, whereas 28/51 plasma cell-culture supernatants
were positive. Levels of cell-associated HIV-1 RNA were
higher in blood samples of viremic individuals than in
undetectable subjects (P = 0.01).
Conclusion
Therapy reduces viral production and shedding in genital
and blood compartments but cell-free HIV-1 remains
detectable in some aviremic patients. Level of genital cell-
free HIV-1 RNA is influenced by systemic viral replication
in contrast to genital cell-associated HIV-1, which may be
influenced by local factors. The little amount of CD4+ T
cells observed in CVS suggests that sexual transmission
occurs independently of HIV-1-infected cells located in
CVS but involve intraepithelial cell-associated HIV-1 or
cell-free virus.
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